Philip S. Low

Next Generation Targeted Therapeutics

Companies Founded

OnTarget logo

Founder and chief science officer

 

Endocyte

Founder, chief science officer since 1998 and member of the Board of Directors since 1995 (purchased by Novartis in 2018 for $2.1 Billion USD)

 

Novosteo

Founder of Novosteo (now part of Quince Therapeutics)

Umoja Biopharma Logo | citybiz

Co-founder, raised over 270 million USD in 2021

 

Morphimmune

Co-founder of Morphimmune (now part of Immunome)

 

eradivir

Co-founder

 

Erythrocure logo

Co-founder